Board okays 70L warrants worth Rs 137.2 cr to promoter group, AOA tweak

Board & Shareholder Meetings View source PDF

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-6.5%1-day move

₹246.95

prior close

₹245.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.4-0.1-0.5-1.5-6.5-8.1-5.6-5.8-5.1-5.7————

Up moveDown movePending

AI summary

Ind-Swift Laboratories board on July 10, 2026 approved issuing up to 70 lakh fully convertible warrants to Essix Biosciences Ltd, a promoter group entity, at Rs 196 per warrant, totalling about Rs 137.20 crore. Each warrant is convertible into one equity share of face value Rs 10 within 18 months. The board also approved altering Article 76 of the AOA to align director retirement rules with current laws and called an EGM on August 5, 2026 to seek shareholder approval.

Likely market impact

Promoter group infusing about Rs 137.20 cr signals confidence, but conversion will dilute existing shareholders. Outcome hinges on EGM nod on Aug 5.